545 results match your criteria: "Marie Lannelongue Hospital[Affiliation]"
Eur J Cardiothorac Surg
November 2024
Cardiothoracic Intensive Care Unit, Marie Lannelongue Hospital, Le Plessis Robinson, France.
Objectives: Prone positioning (PP) has benefits in patients with acute respiratory distress syndrome. The objective of this study was to compare the effects and complications of PP in obese versus non-obese patients with moderate-to-severe acute respiratory distress syndrome after cardiothoracic surgery.
Methods: We retrospectively analysed a database established in 2014-2021 in an intensive care unit.
Sci Rep
November 2024
UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies" (HPPIT), INSERM, Hôpital Marie Lannelongue Et Hôpital Bicêtre, Le Plessis-Robinson Et Le Kremlin-Bicêtre, France.
Targeted vasopeptide therapies have significantly advanced the management of pulmonary arterial hypertension (PAH). However, due to insufficient preclinical evidence regarding the involvement of the endothelin-1 (ET-1) pathway in chronic thromboembolic pulmonary hypertension (CTEPH) pathophysiology, the potential of ET-1 receptor antagonism in treating CTEPH remains uncertain. In this study, we investigated the role of the ET-1 pathway in CTEPH microvasculopathy using a multifaceted approach.
View Article and Find Full Text PDFEur Respir J
November 2024
University of Paris-Saclay, School of Medicine, le Kremlin-Bicêtre, France
Background: Pulmonary hypertension (PH) is an unusual complication of X-linked disease caused by loss-of-function (LOF) variants in the () gene. Patients with LOF may also present dysmorphic facial features, aortic dilation, thrombopenia, and periventricular nodular heterotopia (PVNH).
Methods: We reported clinical, functional, radiologic, and hemodynamic characteristics of patients with LOF variants and PH from the French PH Network.
Fr J Urol
October 2024
Paris Cité University, Department of Urology, AP-HP, Georges-Pompidou European Hospital, 75015 Paris, France.
The synoptic operative report (SOR) is a model with several advantages but still not enough adopted. We studied the performance of a SOR template (FileMaker Pro®, FMP) versus the usual narrative operative report (NOR) template on DxCare® software (DXC) of the urology department at the Georges-Pompidou European Hospital by comparing the number of completed data, the completeness rate, the writing time, and the writing speed and by analyzing the learning curve. Over an 11-week period between March and June 2021, 118 case-control OR for 59 laparoscopic or open, partial or total nephrectomy procedures, for all indications were prospectively created.
View Article and Find Full Text PDFJ Heart Lung Transplant
October 2024
Respiratory & Transplant Medicine, Royal Brompton and Harefield Hospitals, Part of Guy's and St Thomas' NHS Foundation Trust and Imperial College London, London, United Kingdom.
The use of extracorporeal life support (ECLS) throughout the perioperative phase of lung transplantation requires nuanced planning and execution by an integrated team of multidisciplinary experts. To date, no multidisciplinary consensus document has examined the perioperative considerations of how to best manage these patients. To address this challenge, this perioperative utilization of ECLS in lung transplantation consensus statement was approved for development by the International Society for Heart and Lung Transplantation Standards and Guidelines Committee.
View Article and Find Full Text PDFTransplantation
October 2024
Department of Thoracic Surgery and Heart-Lung Transplantation, Marie Lannelongue Hospital, Université Paris-Saclay, Le Plessis Robinson, France.
JAC Antimicrob Resist
October 2024
Infectious Disease Department, Raymond Poincaré Hospital, APHP, Garches, France.
Objectives: To describe the real-life use of temocillin for non-urinary tract infections, to assess its effectiveness in infections caused by ESBL-producing Enterobacterales, and to identify risk factors for treatment failure.
Method: Retrospective multicentric study in 14 tertiary care hospitals, including all patients who received at least one dose of temocillin for ESBL infections from 1 January 2016 to 31 December 2021 for non-urinary tract infections. Failure was a composite criterion defined within 28 day follow-up by persistence or reappearance of signs of infection, and/or switch to suppressive antibiotic treatment and/or death from infection.
J Cardiothorac Vasc Anesth
December 2024
Department of Anesthesiology, Marie Lannelongue Hospital, Paris Saint Joseph Hospital, Le Plessis Robinson, France; Cardiothoracic Intensive Care Unit, Marie Lannelongue Hospital, Paris Saint Joseph Hospital, Le Plessis Robinson, France; Cardiovascular Perfusionist Team, Department of Anesthesiology, Marie Lannelongue Hospital, Paris Saint Joseph Hospital, Le Plessis Robinson, France.
Ann Surg
October 2024
Cardiac and vascular surgery department, Marie Lannelongue hospital, GHPSJ, Le Plessis Robinson, France.
J Pathol
November 2024
Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
T-lymphoblastic lymphoma (T-LBL) and thymoma are two rare primary tumors of the thymus deriving either from T-cell precursors or from thymic epithelial cells, respectively. Some thymoma subtypes (AB, B1, and B2) display numerous reactive terminal deoxynucleotidyl transferase-positive (TdT) T-cell precursors masking epithelial tumor cells. Therefore, the differential diagnosis between T-LBL and TdT T-lymphocyte-rich thymoma could be challenging, especially in the case of needle biopsy.
View Article and Find Full Text PDFRev Esp Cardiol (Engl Ed)
September 2024
Paris Cité University, Paris, France; Department of Cardiology, Bichat and Beaujon Hospital, Assistance Publique des Hopitaux de Paris, Paris, France; UMRS1148 (Unite mixte de Recherche Scientifique), INSERM (Institut National de la Science et de la Recherche Medicale), Paris, France. Electronic address:
Kidney Int Rep
September 2024
Nephrology and Transplantation Department, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris Saclay, Le Kremlin-Bicêtre, France.
Circulation
October 2024
Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria (R.S.-K., I.M.L.).
Background: The European Chronic Thromboembolic Pulmonary Hypertension (CTEPH) registry, conducted between 2007 and 2012, reported the major impact of pulmonary endarterectomy (PEA) on the long-term survival of patients with CTEPH. Since then, 2 additional treatments for inoperable CTEPH have become available: balloon pulmonary angioplasty (BPA), and an approved oral drug therapy with the guanylate cyclase stimulator riociguat. The current registry aimed to evaluate the effect of these new therapeutic approaches in a worldwide context.
View Article and Find Full Text PDFAnn Thorac Surg
September 2024
Thoracic Surgery, Toronto General Hospital, Toronto, Ontario, Canada.
Chronic thromboembolic pulmonary hypertension (CTEPH) is a consequence of unresolved organized thromboembolic obstruction of the pulmonary arteries, which can cause pulmonary hypertension and right ventricular failure. Owing to its subtle signs, determining its exact incidence and prevalence is challenging. Furthermore, CTEPH may also present without any prior venous thromboembolic history, contributing to underdiagnosis and undertreatment.
View Article and Find Full Text PDFPulm Circ
July 2024
Thoracic Surgery Department Marie Lannelongue Hospital, GHPSJ Le Plessis Robinson France.
Balloon pulmonary angioplasty (BPA) to treat chronic thromboembolic pulmonary hypertension (CTEPH) is generally reserved for distal obstruction precluding pulmonary endarterectomy (PEA) but can be used in patients with proximal disease who are at high surgical risk or refuse surgery. This single-center retrospective study compared BPA efficacy in patients with proximal versus distal CTEPH. Of the 478 patients, 36 had proximal disease, follow-up was 11.
View Article and Find Full Text PDFEur Respir J
October 2024
Department of Medicine, Division of Respirology, University Health Network, Toronto, ON, Canada
Despite the progress made in medical therapies for treating pulmonary hypertension (PH), a subset of patients remain susceptible to developing a maladaptive right ventricular phenotype. The effective management of end-stage PH presents substantial challenges, necessitating a multidisciplinary approach and early identification of patients prone to acute decompensation. Identifying potential transplant candidates and assessing the feasibility of such a procedure are pivotal tasks that should be undertaken early in the treatment algorithm.
View Article and Find Full Text PDFJ Vasc Surg
August 2024
Vascular Surgery, University of Bologna - DIMEC, Bologna, Italy.
Intensive Care Med
November 2024
Department of Anaesthesiology and Critical Care, European Hospital Georges Pompidou, Paris, France.
J Vis Exp
July 2024
Department of Cardiovascular Surgery, Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph; Laboratory of Preclinical Research, Department of Research and Innovation, Groupe Hospitalier Paris Saint Joseph; Inserm UMR S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies, Marie Lannelongue Hospital, Groupe Hospitalier Paris Saint Joseph; University of Paris Saclay;
Surg Oncol
October 2024
Department of Thoracic Surgery and Heart-lung Transplantation, Université Paris-Saclay, Marie Lannelongue Hospital, International Center for Thoracic Cancers, Le Plessis Robinson, France.
Objectives: Lower bilobectomy (LBL) leaves a residual pleural space potentially associated with adverse postoperative outcomes. In selected patients, right sleeve lower lobectomy (RSLL) with anastomosis between the middle lobe bronchus and intermediate bronchus is feasible. The outcomes of RSLL and LBL have not been compared.
View Article and Find Full Text PDFEur Respir J
October 2024
Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam, The Netherlands
J Surg Oncol
September 2024
INSERM 1030, Molecular Radiotherapy and Therapeutic innovations, Université Paris Saclay, Villejuif, France.
Background: Leiomyosarcoma of the vena cava (LMS-VC) is a rare entity with poor oncological outcomes and a lack of histological staging prognostic factors.
Methods: Outcomes of consecutive patients operated on LMS-VC between March 2003 and May 2022, in two specialized sarcoma centers were reported.
Result: Forty-one patients were identified.
Respir Med Res
November 2024
University of Paris-Saclay, School of Medicine, le Kremlin-Bicêtre, France; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Bicêtre Hospital, le Kremlin-Bicêtre, France; INSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", Marie Lannelongue Hospital and Bicêtre Hospital, France. Electronic address:
Pulmonary hypertension (PH) continues to present significant challenges to the medical community, both in terms of diagnosis and treatment. The advent of the updated 2022 European Society of Cardiology (ESC) and European Respiratory Society (ERS) guidelines has introduced pivotal changes that reflect the rapidly advancing understanding of this complex disease. These changes include a revised definition of PH, updates to the classification system, and treatment algorithm.
View Article and Find Full Text PDFAnn Transl Med
June 2024
Intensive Care Unit, Versailles Hospital, Le Chesnay, France.
Background: Hypophosphatemia has been reported to impair diaphragmatic function in patients with chronic obstructive pulmonary disease (COPD). However, little is known about the role of dysphosphatemia at admission [plasmatic phosphate concentration at intensive care unit (ICU) admission (T0-Ph)] to the ICU and respiratory outcomes among patients with severe acute COPD exacerbation. We aimed to assess the value of T0-Ph as a predictive factor of invasive mechanical ventilation (MV) during ICU stay.
View Article and Find Full Text PDFJ Heart Lung Transplant
October 2024
Department of Thoracic Surgery and Lung Transplantation, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France.
Background: Pleuroparenchymal fibroelastosis (PPFE) has no currently available specific treatment. Benefits of lung transplantation (LT) for PPFE are poorly documented.
Methods: We conducted a nation-wide multicentric retrospective study in patients who underwent lung or heart-lung transplantation for chronic end-stage lung disease secondary to PPFE between 2012 and 2022 in France.